Expression of interleukin-18 in coronary plaque obtained by atherectomy from patients with stable and unstable angina

Thrombosis Research

Volumn 121, Issue 2, 2007, Pages 275-279

  Nishihira, Kensaku ^a   Imamura, Takuroh ^a   Hatakeyama, Kinta ^a   Yamashita, Atsushi ^a   Shibata, Yoshisato ^b   Date, Haruhiko ^a   Manabe, Ichiro ^c   Nagai, Ryozo ^c   Kitamura, Kazuo ^a   Asada, Yujiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Miyazaki Medical Association Hospital Cardiovascular Center   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angina pectoris; Atherectomy; Atherothrombosis; Immunohistochemistry; Interleukin 18

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIRECTIONAL ATHERECTOMY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ATHERECTOMY, CORONARY; CORONARY THROMBOSIS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-18; MALE; MIDDLE AGED;

EID: 36249006534     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.04.003     Document Type: Article

References (20)

1. Fuster V., Moreno P.R., Fayad Z.A., Corti R., and Badimon J.J. Atherothrombosis and high-risk plaque part I: evolving concepts. J Am Coll Cardiol 46 (2005) 937-954
2. Lutgens E., van Suylen R.J., Faber B.C., Gijbels M.J., Eurlings P.M., Bijnen A.P., et al. Atherosclerotic plaque rupture. Local or systemic process?. Arterioscler Thromb Vasc Biol 23 (2003) 2123-2130
3. Nishihira K., Imamura T., Yamashita A., Hatakeyama K., Shibata Y., Nagatomo Y., et al. Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy. Eur Heart J 27 (2006) 1685-1689
4. Chalikias G.K., Tziakas D.N., Kaski J.C., Hatzinikolaou E.I., Stakos D.A., Tentes I.K., et al. Interleukin-18: interleukin-10 ratio and in-hospital adverse event in patients with acute coronary syndrome. Atherosclerosis 182 (2005) 135-143
5. Mühl H., and Pfeilschifter J. Interluekin-18 bioactivity: a novel target for immuno-pharmacological anti-inflammatory intervention. Eur J Pharmacol 500 (2004) 63-71
6. Dinarello C.A. Interleukin-18: a proinflammatory cytokine. Eur Cytokine Netw 11 (2000) 483-486
7. Mallat Z., Corbaz A., Scoazec A., Besnard S., Leséche G., Chvatchko Y., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104 (2001) 1598-1603
8. Gerdes N., Sukhova G.K., Libby P., Reynolds R.S., Young J.L., and Schönbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 195 (2002) 245-257
9. Whitman S.C., Ravisankar P., and Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 90 (2002) e34-e38
10. Mallat Z., Corbaz A., Scoazec A., Graber P., Alouani S., Esposito B., et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 89 (2001) e41-e45
11. Campeau L. Grading of angina pectoris. Circulation 54 (1976) 522-533
12. Braunwald E. Unstable angina: a classification. Circulation 80 (1989) 410-414
13. Elhage R., Jawien J., Rudling M., Ljunggren H.-G., Takeda K., Akira S., et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 59 (2003) 234-240
14. Blankenberg S., et al., on behalf of the PRIME study group. Interleukin-18 and the risk of coronary heart disease in European men. The prospective epidemiological study of myocardial infarction (PRIME). Circulation 108 (2003) 2453-2459
15. Koenig W., Khuseyinova N., Baumert J., Thorand B., Loewel H., Chambless L., et al. Increased concentrations of c-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women. Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol 26 (2006) 2745-2751
16. Mallat Z., Henry P., Fressonnet R., Alouani S., Scoazec A., Beaufils P., et al. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 88 (2002) 467-479
17. Baiidya S.G., Zeng Q.T., Wang X., and Guo H.-P. T helper cell related interleukins and the angiographic morphology in unstable angina. Cytokine 30 (2005) 303-310
18. Kawasaki D., Tsujino T., Morimoto S., Fujioka Y., Naito Y., Okumura T., et al. Usefulness of circulating interleukin-18 concentration in acute myocardial infarction as a risk factor for late restenosis after emergency coronary angioplasty. Am J Cardiol 91 (2003) 1258-1261
19. Blankenberg S., et al., for the AtheroGene investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106 (2002) 24-30
20. Tiret L., Godefroy T., Lubos E., Nicaud V., Tregouet D.A., Barbaux S., et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 112 (2005) 643-650